You are here

  • Home
  • Archive
  • Volume 10, Issue 7
  • Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood

 

Online download statistics by month:

Online download statistics by month: July 2022 to July 2025

AbstractFullPdf
Jul 2022798825285
Aug 2022472486186
Sep 2022246253131
Oct 202216717889
Nov 202211011144
Dec 202217617746
Jan 202310210234
Feb 202315816052
Mar 2023707345
Apr 2023666633
May 2023585920
Jun 2023515119
Jul 2023434323
Aug 2023686931
Sep 2023565741
Oct 2023383826
Nov 2023565626
Dec 2023363619
Jan 2024444524
Feb 2024616141
Mar 2024363669
Apr 2024363628
May 2024485025
Jun 2024373635
Jul 2024434424
Aug 2024232314
Sep 20242828394
Oct 2024363717
Nov 2024484921
Dec 2024414223
Jan 2025484823
Feb 202517417434
Mar 2025575745
Apr 2025808039
May 2025464735
Jun 2025282819
Jul 2025110
Total368637622060